Nitecapone (INN; OR-462) is a drug which acts as a selective inhibitor of the enzyme catechol O-methyl transferase (COMT). It was patented as an antiparkinson medication but was never marketed.
Nitecapone (INN; OR-462) is a drug which acts as a selective inhibitor of the enzyme catechol O-methyl transferase (COMT). It was patented as an antiparkinson medication but was never marketed.
==See also== List of investigational Parkinson's disease drugs Catechol-O-methyltransferase inhibitor
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).